tv.qiagenbioinformatics.com marketingbiox@qiagen.com https://tv.qiagenbioinformatics.com Watch tutorials, interviews and much more on our web based TV channel! en-us Visualplatform http://blogs.law.harvard.edu/tech/rss tv.qiagenbioinformatics.com CLC bio TV Watch tutorials, interviews and much more on our web based TV channel! clc bio tv, bioinformatics, genomics, research episodic no https://tv.qiagenbioinformatics.com/files/rv0.0/sitelogo.gif https://tv.qiagenbioinformatics.com http://tv.qiagenbioinformatics.com/photo/112165509/guardant-dr-lauren-lawrence <p><p><strong>IR Deep Dive | Dr. Lauren Lawrence</strong></p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/112165509/guardant-dr-lauren-lawrence"><img src="http://tv.qiagenbioinformatics.com/64968579/112165509/258d10926db0c12f875c215795f04c79/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/112165509 Fri, 25 Apr 2025 18:31:36 GMT Guardant | Dr. Lauren Lawrence IR Deep Dive | Dr. Lauren Lawrence IR Deep Dive | Dr. Lauren Lawrence tv.qiagenbioinformatics.com 02:25 <p><p><strong>IR Deep Dive | Dr. Lauren Lawrence</strong></p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/112165509/guardant-dr-lauren-lawrence"><img src="http://tv.qiagenbioinformatics.com/64968579/112165509/258d10926db0c12f875c215795f04c79/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/107543206/qiagen-public-health-virtual <p><p>This event will feature four public health experts highlighting exciting collaborations within the PHL space across various workflows, including Antimicrobial Resistance Tracking, Vector-borne Disease Monitoring, Waterborne Pathogen Detection, and PulseNet Extraction/Sequencing. Come learn more about pathogen detection from the unseen heroes of public health!</p> <p>The purpose of the QIAGEN Public Health Virtual Symposium is to inspire and equip public health professionals with the latest insights and innovative solutions to advance public health laboratory practices, fostering stronger collaborations and improving outcomes in public health initiatives.</p> <p>Speakers:</p> <p>Alex Rossheim, MS, Colorado Department of Public Health and Environment:</p> <p>From Extraction to Sequencing: Evaluating QIAGEN Workflows for PulseNet Pathogens</p> <p>Brenna McGruder, PhD, Florida Bureau of Public Health Labs - Jacksonville:</p> <p>Disaster Patrol: Utilizing Digital PCR to Monitor Dangerous Pathogens Across Storm Cycles in Hurricane-Affected Regions</p> <p>Becca Harrell, MLT, Tennessee Department of Health:</p> <p>Enhancing Microbial Detection: Boosting Precision, Accuracy, and Sensitivity with Digital PCR for Pathogen Detection</p> <p>Doris Di, PhD, Hawaii State Department of Health:</p> <p>Flushing the Threat: Tracking Antimicrobial Resistance in Hawaiian Communities through Wastewater Based Epidemiology</p> <p></p> </p><p><a href="http://tv.qiagenbioinformatics.com/photo/107543206/qiagen-public-health-virtual"><img src="http://tv.qiagenbioinformatics.com/64968556/107543206/9b26607cc40ab99e00db79e06d05d024/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/107543206 Tue, 10 Dec 2024 09:51:59 GMT QIAGEN Public Health Virtual Symposium This event will feature four public health experts highlighting exciting collaborations within the PHL space across various workflows, including Antimicrobial Resistance Tracking, Vector-borne Disease Monitoring, Waterborne Pathogen Detection, and PulseNet Extraction/Sequencing. Come learn more about pathogen detection from the unseen heroes of public health! The purpose of the QIAGEN Public Health Virtual Symposium is to inspire and equip public health professionals with the latest insights and innovative solutions to advance public health laboratory practices, fostering stronger collaborations and improving outcomes in public health initiatives. Speakers: Alex Rossheim, MS, Colorado Department of Public Health and Environment: From Extraction to Sequencing: Evaluating QIAGEN Workflows for PulseNet Pathogens Brenna McGruder, PhD, Florida Bureau of Public Health Labs - Jacksonville: Disaster Patrol: Utilizing Digital PCR to Monitor Dangerous Pathogens Across Storm Cycles in Hurricane-Affected Regions Becca Harrell, MLT, Tennessee Department of Health: Enhancing Microbial Detection: Boosting Precision, Accuracy, and Sensitivity with Digital PCR for Pathogen Detection Doris Di, PhD, Hawaii State Department of Health: Flushing the Threat: Tracking Antimicrobial Resistance in Hawaiian Communities through Wastewater Based Epidemiology This event will feature four public health experts highlighting exciting collaborations within the PHL space across various workflows, including Antimicrobial Resistance Tracking, Vector-borne Disease Monitoring, Waterborne Pathogen Detection, and... tv.qiagenbioinformatics.com 01:55:17 <p><p>This event will feature four public health experts highlighting exciting collaborations within the PHL space across various workflows, including Antimicrobial Resistance Tracking, Vector-borne Disease Monitoring, Waterborne Pathogen Detection, and PulseNet Extraction/Sequencing. Come learn more about pathogen detection from the unseen heroes of public health!</p> <p>The purpose of the QIAGEN Public Health Virtual Symposium is to inspire and equip public health professionals with the latest insights and innovative solutions to advance public health laboratory practices, fostering stronger collaborations and improving outcomes in public health initiatives.</p> <p>Speakers:</p> <p>Alex Rossheim, MS, Colorado Department of Public Health and Environment:</p> <p>From Extraction to Sequencing: Evaluating QIAGEN Workflows for PulseNet Pathogens</p> <p>Brenna McGruder, PhD, Florida Bureau of Public Health Labs - Jacksonville:</p> <p>Disaster Patrol: Utilizing Digital PCR to Monitor Dangerous Pathogens Across Storm Cycles in Hurricane-Affected Regions</p> <p>Becca Harrell, MLT, Tennessee Department of Health:</p> <p>Enhancing Microbial Detection: Boosting Precision, Accuracy, and Sensitivity with Digital PCR for Pathogen Detection</p> <p>Doris Di, PhD, Hawaii State Department of Health:</p> <p>Flushing the Threat: Tracking Antimicrobial Resistance in Hawaiian Communities through Wastewater Based Epidemiology</p> <p></p> </p><p><a href="http://tv.qiagenbioinformatics.com/photo/107543206/qiagen-public-health-virtual"><img src="http://tv.qiagenbioinformatics.com/64968556/107543206/9b26607cc40ab99e00db79e06d05d024/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/107524512/qiagen-bioinformatics-public-health-1 <p><p>Join us for the second edition of QIAGEN’s Bioinformatics Public Health Summit. This virtual event will focus on applications and tools for NGS data analysis in the public health laboratory setting. You’ll be hearing about analyses related to: enteric diseases, SARS-CoV-2, mpox, TB, PFAS, wastewater testing, and anti-microbial resistance from the QIAGEN team as well as guest speakers.</p> <p>Who should join? Public health professionals, including lab scientists, epidemiologists, and infectious disease specialists interested in NGS data analysis.</p> </p><p><a href="http://tv.qiagenbioinformatics.com/photo/107524512/qiagen-bioinformatics-public-health-1"><img src="http://tv.qiagenbioinformatics.com/64968576/107524512/8394887dcee713e940a5e8f58159bef8/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/107524512 Mon, 09 Dec 2024 17:26:40 GMT QIAGEN Bioinformatics Public Health Summit Join us for the second edition of QIAGEN’s Bioinformatics Public Health Summit. This virtual event will focus on applications and tools for NGS data analysis in the public health laboratory setting. You’ll be hearing about analyses related to: enteric diseases, SARS-CoV-2, mpox, TB, PFAS, wastewater testing, and anti-microbial resistance from the QIAGEN team as well as guest speakers. Who should join? Public health professionals, including lab scientists, epidemiologists, and infectious disease specialists interested in NGS data analysis. Join us for the second edition of QIAGEN’s Bioinformatics Public Health Summit. This virtual event will focus on applications and tools for NGS data analysis in the public health laboratory setting. You’ll be hearing about analyses related to:... tv.qiagenbioinformatics.com 01:27:10 <p><p>Join us for the second edition of QIAGEN’s Bioinformatics Public Health Summit. This virtual event will focus on applications and tools for NGS data analysis in the public health laboratory setting. You’ll be hearing about analyses related to: enteric diseases, SARS-CoV-2, mpox, TB, PFAS, wastewater testing, and anti-microbial resistance from the QIAGEN team as well as guest speakers.</p> <p>Who should join? Public health professionals, including lab scientists, epidemiologists, and infectious disease specialists interested in NGS data analysis.</p> </p><p><a href="http://tv.qiagenbioinformatics.com/photo/107524512/qiagen-bioinformatics-public-health-1"><img src="http://tv.qiagenbioinformatics.com/64968576/107524512/8394887dcee713e940a5e8f58159bef8/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/90542138/part-2-ai-powered-hereditary <p>Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows.<p></p> <p>Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis.</p> <p>Part II: Roundtable discussion with genomics experts – November 9, 2023</p> <p>A panel discussion featuring experts in the field of clinical genomics that will explore the challenges and opportunities in the future of inherited disease diagnostic testing.</p> <p>For the list of speakers and session information, visit our event page here.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/90542138/part-2-ai-powered-hereditary"><img src="http://tv.qiagenbioinformatics.com/64968555/90542138/12f4cb5889b569104cf1f1998f89d8a6/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/90542138 Thu, 30 Nov 2023 12:59:35 GMT Part 2: AI-Powered Hereditary Disease Diagnostics: Closing the Gap in... Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows. Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis. Part II: Roundtable discussion with genomics experts – November 9, 2023 A panel discussion featuring experts in the field of clinical genomics that will explore the challenges and opportunities in the future of inherited disease diagnostic testing. For the list of speakers and session information, visit our event page here. Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data... tv.qiagenbioinformatics.com 52:27 <p>Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows.<p></p> <p>Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis.</p> <p>Part II: Roundtable discussion with genomics experts – November 9, 2023</p> <p>A panel discussion featuring experts in the field of clinical genomics that will explore the challenges and opportunities in the future of inherited disease diagnostic testing.</p> <p>For the list of speakers and session information, visit our event page here.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/90542138/part-2-ai-powered-hereditary"><img src="http://tv.qiagenbioinformatics.com/64968555/90542138/12f4cb5889b569104cf1f1998f89d8a6/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> AI hereditary hereditary ngs summit http://tv.qiagenbioinformatics.com/photo/89839701/closing-the-gap-in-clinical-exome-1 <p>Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows.<p></p> <p>Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis.</p> <p>Part I: Educational talks – October 12, 2023</p> <p>An education session exploring the latest databases, software, and services for germline secondary and tertiary NGS analysis. Topics will include:</p> <p>How labs can achieve clinical exome completeness with AI-enriched and manually curated content<br> How labs can apply enhanced phenotype-driven ranking in clinical cases<br> How labs can safely use a “smart” approach to AI to reach the best possible chance of reaching a diagnosis</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/89839701/closing-the-gap-in-clinical-exome-1"><img src="http://tv.qiagenbioinformatics.com/64968556/89839701/d68c04fa591eea4b57f358238dda981c/standard/download-6-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/89839701 Fri, 20 Oct 2023 17:12:15 GMT Closing the Gap in Clinical Exome Completeness - Part 1 - EU Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows. Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis. Part I: Educational talks – October 12, 2023 An education session exploring the latest databases, software, and services for germline secondary and tertiary NGS analysis. Topics will include: How labs can achieve clinical exome completeness with AI-enriched and manually curated content How labs can apply enhanced phenotype-driven ranking in clinical cases How labs can safely use a “smart” approach to AI to reach the best possible chance of reaching a diagnosis Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data... tv.qiagenbioinformatics.com 01:58:35 <p>Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows.<p></p> <p>Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis.</p> <p>Part I: Educational talks – October 12, 2023</p> <p>An education session exploring the latest databases, software, and services for germline secondary and tertiary NGS analysis. Topics will include:</p> <p>How labs can achieve clinical exome completeness with AI-enriched and manually curated content<br> How labs can apply enhanced phenotype-driven ranking in clinical cases<br> How labs can safely use a “smart” approach to AI to reach the best possible chance of reaching a diagnosis</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/89839701/closing-the-gap-in-clinical-exome-1"><img src="http://tv.qiagenbioinformatics.com/64968556/89839701/d68c04fa591eea4b57f358238dda981c/standard/download-6-thumbnail.jpg" width="75" height=""/></a></p> 2023 Clinical Hereditary Disease Diagnostics Summit artificial intelligence http://tv.qiagenbioinformatics.com/photo/89839695/closing-the-gap-in-clinical-exome <p>Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows. <p>Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis.</p> <p>Part I: Educational talks – October 12, 2023</p> <p>An education session exploring the latest databases, software, and services for germline secondary and tertiary NGS analysis. Topics will include:</p> <p>How labs can achieve clinical exome completeness with AI-enriched and manually curated content<br> How labs can apply enhanced phenotype-driven ranking in clinical cases<br> How labs can safely use a “smart” approach to AI to reach the best possible chance of reaching a diagnosis</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/89839695/closing-the-gap-in-clinical-exome"><img src="http://tv.qiagenbioinformatics.com/64968566/89839695/70795a392f7be13bb387ed0e08928a09/standard/download-6-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/89839695 Fri, 20 Oct 2023 17:11:27 GMT Closing the Gap in Clinical Exome Completeness - Part 1 - NA Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows. Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis. Part I: Educational talks – October 12, 2023 An education session exploring the latest databases, software, and services for germline secondary and tertiary NGS analysis. Topics will include: How labs can achieve clinical exome completeness with AI-enriched and manually curated content How labs can apply enhanced phenotype-driven ranking in clinical cases How labs can safely use a “smart” approach to AI to reach the best possible chance of reaching a diagnosis Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data... tv.qiagenbioinformatics.com 01:34:02 <p>Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few candidate variants becomes more difficult. This issue is further amplified in cases where labs must use deep phenotyping of patients and compare that to reference genotype-phenotype knowledge associated with each candidate variant. To overcome these challenges, labs are beginning to implement Artificial Intelligence (AI) in their variant analysis, interpretation and reporting workflows. <p>Join us for our 2023 Clinical Hereditary Disease Diagnostics Summit, a free-to-attend, two-part event exploring the opportunities and limitations of AI in hereditary disease diagnostics. Designed to help clinical diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of hereditary disease diagnostics, as well as educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis.</p> <p>Part I: Educational talks – October 12, 2023</p> <p>An education session exploring the latest databases, software, and services for germline secondary and tertiary NGS analysis. Topics will include:</p> <p>How labs can achieve clinical exome completeness with AI-enriched and manually curated content<br> How labs can apply enhanced phenotype-driven ranking in clinical cases<br> How labs can safely use a “smart” approach to AI to reach the best possible chance of reaching a diagnosis</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/89839695/closing-the-gap-in-clinical-exome"><img src="http://tv.qiagenbioinformatics.com/64968566/89839695/70795a392f7be13bb387ed0e08928a09/standard/download-6-thumbnail.jpg" width="75" height=""/></a></p> 2023 Clinical Hereditary Disease Diagnostics Summit artificial intelligence http://tv.qiagenbioinformatics.com/photo/86079576/2023-clinical-oncology-summit-part-3 <p>How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting <p>We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023.</p> <p>The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/86079576/2023-clinical-oncology-summit-part-3"><img src="http://tv.qiagenbioinformatics.com/64968566/86079576/048087bef3309ad621c387ae93a37050/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/86079576 Fri, 26 May 2023 14:12:24 GMT 2023 Clinical Oncology Summit: Part 2 - NA How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput. How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our... tv.qiagenbioinformatics.com 01:24:33 <p>How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting <p>We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023.</p> <p>The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/86079576/2023-clinical-oncology-summit-part-3"><img src="http://tv.qiagenbioinformatics.com/64968566/86079576/048087bef3309ad621c387ae93a37050/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> oncology oncology summit 2023 http://tv.qiagenbioinformatics.com/photo/86079566/2023-clinical-oncology-summit-part-2 <p>How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting <p>We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023.</p> <p>The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/86079566/2023-clinical-oncology-summit-part-2"><img src="http://tv.qiagenbioinformatics.com/64968558/86079566/fd82f44914a1f0801c2dacb546052a5f/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/86079566 Fri, 26 May 2023 14:11:25 GMT 2023 Clinical Oncology Summit: Part 2 - EMEA How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput. How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our... tv.qiagenbioinformatics.com 01:17:47 <p>How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting <p>We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023.</p> <p>The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/86079566/2023-clinical-oncology-summit-part-2"><img src="http://tv.qiagenbioinformatics.com/64968558/86079566/fd82f44914a1f0801c2dacb546052a5f/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> oncology oncology summit 2023 http://tv.qiagenbioinformatics.com/photo/85625975/2023-clinical-oncology-summit-part-1 <p>How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting<br> We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit.<p></p> <p>The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/85625975/2023-clinical-oncology-summit-part-1"><img src="http://tv.qiagenbioinformatics.com/64968560/85625975/c7986ba3682144d1e03122bbf786a9d4/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/85625975 Mon, 01 May 2023 19:30:14 GMT 2023 Clinical Oncology Summit: Part 1 - Americas How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput. How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our... tv.qiagenbioinformatics.com 01:50:27 <p>How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting<br> We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit.<p></p> <p>The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/85625975/2023-clinical-oncology-summit-part-1"><img src="http://tv.qiagenbioinformatics.com/64968560/85625975/c7986ba3682144d1e03122bbf786a9d4/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> oncology oncology summit 2023 http://tv.qiagenbioinformatics.com/photo/85589464/2023-clinical-oncology-summit-part <p>How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting <p>We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit.</p> <p>The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.</p> <p>Meet the speakers and view the full agenda here.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/85589464/2023-clinical-oncology-summit-part"><img src="http://tv.qiagenbioinformatics.com/64968556/85589464/b19839b0fe06278f92a8a6bb292fd1c9/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/85589464 Thu, 27 Apr 2023 19:31:29 GMT 2023 Clinical Oncology Summit: Part 1 - EMEA How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput. Meet the speakers and view the full agenda here. How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our... tv.qiagenbioinformatics.com 01:24:00 <p>How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting <p>We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit.</p> <p>The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.</p> <p>Meet the speakers and view the full agenda here.</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/85589464/2023-clinical-oncology-summit-part"><img src="http://tv.qiagenbioinformatics.com/64968556/85589464/b19839b0fe06278f92a8a6bb292fd1c9/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> oncology oncology summit 2023 http://tv.qiagenbioinformatics.com/photo/81422637/emerging-clinical-trends-in-1 <p>Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing <p>Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.</p> <p>Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.</p> <p>An expert panel of leading medical geneticists, variant scientists and bioinformaticians will discuss emerging scientific and clinical trends in germline NGS testing.</p> <p>Attendees will gain:</p> <p>Insight into how leading laboratories address bottlenecks in their NGS data pipelines<br> Tips on how to solve process inefficiencies of critical workflow components, including variant curation and interpreting rare or novel variants<br> An outlook on how germline NGS analysis and interpretation will change in the next 5 years and how to remain at the forefront of innovation</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/81422637/emerging-clinical-trends-in-1"><img src="http://tv.qiagenbioinformatics.com/64968569/81422637/5bd9dcc53e86885298fe0b0f683b2b65/standard/download-22-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/81422637 Thu, 17 Nov 2022 19:00:47 GMT Emerging clinical trends in germline NGS testing: Expert Panel Discussion in USA Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation. Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers. An expert panel of leading medical geneticists, variant scientists and bioinformaticians will discuss emerging scientific and clinical trends in germline NGS testing. Attendees will gain: Insight into how leading laboratories address bottlenecks in their NGS data pipelines Tips on how to solve process inefficiencies of critical workflow components, including variant curation and interpreting rare or novel variants An outlook on how germline NGS analysis and interpretation will change in the next 5 years and how to remain at the forefront of innovation Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses,... tv.qiagenbioinformatics.com 01:22:05 <p>Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing <p>Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.</p> <p>Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.</p> <p>An expert panel of leading medical geneticists, variant scientists and bioinformaticians will discuss emerging scientific and clinical trends in germline NGS testing.</p> <p>Attendees will gain:</p> <p>Insight into how leading laboratories address bottlenecks in their NGS data pipelines<br> Tips on how to solve process inefficiencies of critical workflow components, including variant curation and interpreting rare or novel variants<br> An outlook on how germline NGS analysis and interpretation will change in the next 5 years and how to remain at the forefront of innovation</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/81422637/emerging-clinical-trends-in-1"><img src="http://tv.qiagenbioinformatics.com/64968569/81422637/5bd9dcc53e86885298fe0b0f683b2b65/standard/download-22-thumbnail.jpg" width="75" height=""/></a></p> hereditary hereditary ngs summit qci interpret http://tv.qiagenbioinformatics.com/photo/81412632/emerging-clinical-trends-in <p><p><b>Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing</b></p><b> </b><p>Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.</p> <p>Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.</p> <p>An expert panel of leading medical geneticists, variant scientists and bioinformaticians will discuss emerging scientific and clinical trends in germline NGS testing.</p> <p>Attendees will gain:</p> <ul><li>Insight into how leading laboratories address bottlenecks in their NGS data pipelines</li><li> Tips on how to solve process inefficiencies of critical workflow components, including variant curation and interpreting rare or novel variants</li><li> An outlook on how germline NGS analysis and interpretation will change in the next 5 years and how to remain at the forefront of innovation</li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/81412632/emerging-clinical-trends-in"><img src="http://tv.qiagenbioinformatics.com/64968577/81412632/7f32e5b3f1a7b21070a98391d15d4557/standard/download-13-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/81412632 Thu, 17 Nov 2022 07:03:21 GMT Emerging clinical trends in germline NGS testing: Expert Panel Discussion in... Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation. Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers. An expert panel of leading medical geneticists, variant scientists and bioinformaticians will discuss emerging scientific and clinical trends in germline NGS testing. Attendees will gain: Insight into how leading laboratories address bottlenecks in their NGS data pipelines Tips on how to solve process inefficiencies of critical workflow components, including variant curation and interpreting rare or novel variants An outlook on how germline NGS analysis and interpretation will change in the next 5 years and how to remain at the forefront of innovation Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses,... tv.qiagenbioinformatics.com 01:10:25 <p><p><b>Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing</b></p><b> </b><p>Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.</p> <p>Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.</p> <p>An expert panel of leading medical geneticists, variant scientists and bioinformaticians will discuss emerging scientific and clinical trends in germline NGS testing.</p> <p>Attendees will gain:</p> <ul><li>Insight into how leading laboratories address bottlenecks in their NGS data pipelines</li><li> Tips on how to solve process inefficiencies of critical workflow components, including variant curation and interpreting rare or novel variants</li><li> An outlook on how germline NGS analysis and interpretation will change in the next 5 years and how to remain at the forefront of innovation</li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/81412632/emerging-clinical-trends-in"><img src="http://tv.qiagenbioinformatics.com/64968577/81412632/7f32e5b3f1a7b21070a98391d15d4557/standard/download-13-thumbnail.jpg" width="75" height=""/></a></p> hereditary hereditary ngs summit qci interpret http://tv.qiagenbioinformatics.com/photo/79848955/next-gen-software-workflow-for-1 <p><p><b>Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing</b></p><p>Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.</p><p>Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.</p><p>Part I: Thursday, October 13, 2022&nbsp;</p><p>An informative scientific and clinical segment focusing on how to streamline and scale components of the NGS analytical workflow.</p><p>Attendees will learn:</p><ul><li>How to simplify NGS secondary analysis workflows to 5 steps</li><li>How to solve every hereditary disorder case for all types of mutations</li><li>How to address current challenges in germline and exome analytics&nbsp;</li></ul>Click <a href="https://digitalinsights.qiagen.com/products-overview/clinical-insights-portfolio/qiagen-clinical-insight/qci-interpret/">here</a> to learn more.<br></p><p><a href="http://tv.qiagenbioinformatics.com/photo/79848955/next-gen-software-workflow-for-1"><img src="http://tv.qiagenbioinformatics.com/64968561/79848955/7076286132fd906f856326e5d50e4db5/standard/download-20-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/79848955 Tue, 18 Oct 2022 15:18:39 GMT Next-gen software workflow for germline testing: QIAGEN Expert talks in Europe Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline TestingOver the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.Part I: Thursday, October 13, 2022An informative scientific and clinical segment focusing on how to streamline and scale components of the NGS analytical workflow.Attendees will learn:How to simplify NGS secondary analysis workflows to 5 stepsHow to solve every hereditary disorder case for all types of mutationsHow to address current challenges in germline and exome analyticsClick here to learn more. Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline TestingOver the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses,... tv.qiagenbioinformatics.com 01:50:33 <p><p><b>Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing</b></p><p>Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.</p><p>Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.</p><p>Part I: Thursday, October 13, 2022&nbsp;</p><p>An informative scientific and clinical segment focusing on how to streamline and scale components of the NGS analytical workflow.</p><p>Attendees will learn:</p><ul><li>How to simplify NGS secondary analysis workflows to 5 steps</li><li>How to solve every hereditary disorder case for all types of mutations</li><li>How to address current challenges in germline and exome analytics&nbsp;</li></ul>Click <a href="https://digitalinsights.qiagen.com/products-overview/clinical-insights-portfolio/qiagen-clinical-insight/qci-interpret/">here</a> to learn more.<br></p><p><a href="http://tv.qiagenbioinformatics.com/photo/79848955/next-gen-software-workflow-for-1"><img src="http://tv.qiagenbioinformatics.com/64968561/79848955/7076286132fd906f856326e5d50e4db5/standard/download-20-thumbnail.jpg" width="75" height=""/></a></p> hereditary hereditary ngs summit qci interpret http://tv.qiagenbioinformatics.com/photo/79848961/next-gen-software-workflow-for <p><p> <b>Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing</b></p><p>Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.</p><p>Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.&nbsp;&nbsp;</p><p>Part I: Thursday, October 13, 2022&nbsp;</p><p>An informative scientific and clinical segment focusing on how to streamline and scale components of the NGS analytical workflow.</p><p>Attendees will learn:</p><ul><li>How to simplify NGS secondary analysis workflows to 5 steps</li><li>How to solve every hereditary disorder case for all types of mutations</li><li>How to address current challenges in germline and exome analytics&nbsp;</li></ul>Click <a href="https://digitalinsights.qiagen.com/products-overview/clinical-insights-portfolio/qiagen-clinical-insight/qci-interpret/">here</a> to learn more.<br></p><p><a href="http://tv.qiagenbioinformatics.com/photo/79848961/next-gen-software-workflow-for"><img src="http://tv.qiagenbioinformatics.com/64968560/79848961/844065c6f09af7737f2bd428973f3272/standard/download-9-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/79848961 Tue, 18 Oct 2022 15:00:31 GMT Next-gen software workflow for germline testing: QIAGEN Expert talks in USA Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline TestingOver the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.Part I: Thursday, October 13, 2022An informative scientific and clinical segment focusing on how to streamline and scale components of the NGS analytical workflow.Attendees will learn:How to simplify NGS secondary analysis workflows to 5 stepsHow to solve every hereditary disorder case for all types of mutationsHow to address current challenges in germline and exome analyticsClick here to learn more. Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline TestingOver the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses,... tv.qiagenbioinformatics.com 02:06:35 <p><p> <b>Hereditary NGS Clinical Summit Series: Build a Next-Gen Software Workflow for Germline Testing</b></p><p>Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.</p><p>Advance your lab’s germline testing capabilities by learning how to build a next-gen software workflow, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers.&nbsp;&nbsp;</p><p>Part I: Thursday, October 13, 2022&nbsp;</p><p>An informative scientific and clinical segment focusing on how to streamline and scale components of the NGS analytical workflow.</p><p>Attendees will learn:</p><ul><li>How to simplify NGS secondary analysis workflows to 5 steps</li><li>How to solve every hereditary disorder case for all types of mutations</li><li>How to address current challenges in germline and exome analytics&nbsp;</li></ul>Click <a href="https://digitalinsights.qiagen.com/products-overview/clinical-insights-portfolio/qiagen-clinical-insight/qci-interpret/">here</a> to learn more.<br></p><p><a href="http://tv.qiagenbioinformatics.com/photo/79848961/next-gen-software-workflow-for"><img src="http://tv.qiagenbioinformatics.com/64968560/79848961/844065c6f09af7737f2bd428973f3272/standard/download-9-thumbnail.jpg" width="75" height=""/></a></p> hereditary hereditary ngs summit qci interpret http://tv.qiagenbioinformatics.com/photo/76302975/break-the-data-bottleneck-summit <p>Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the Data Bottleneck Summit<p></p> <p>At the Break the Data Bottleneck Summit, our experts will demonstrate how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed, expertise, and confidence of large hospital networks and university centers.</p> <p>The Break the Data Bottleneck Summit is your opportunity to:</p> <p>Learn how to accelerate your bioinformatics pipeline from FASTQ to report<br> Gain valuable insights into variant curation and the importance of evidence<br> Find out how your lab can stay up-to-date on guidelines, therapies, and trials and generate comprehensive, patient-specific reports</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/76302975/break-the-data-bottleneck-summit"><img src="http://tv.qiagenbioinformatics.com/64968570/76302975/d6ed11cf18ac5e43da7695488466f0fd/standard/download-6-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/76302975 Mon, 27 Jun 2022 19:45:34 GMT Break the data bottleneck summit: Precision Oncology Expert Panel in Americas Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the Data Bottleneck Summit At the Break the Data Bottleneck Summit, our experts will demonstrate how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed, expertise, and confidence of large hospital networks and university centers. The Break the Data Bottleneck Summit is your opportunity to: Learn how to accelerate your bioinformatics pipeline from FASTQ to report Gain valuable insights into variant curation and the importance of evidence Find out how your lab can stay up-to-date on guidelines, therapies, and trials and generate comprehensive, patient-specific reports Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the Data Bottleneck Summit At the Break the Data Bottleneck Summit, our experts will demonstrate how small to mid-sized clinical diagnostic labs can compete to... tv.qiagenbioinformatics.com 01:13:40 <p>Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the Data Bottleneck Summit<p></p> <p>At the Break the Data Bottleneck Summit, our experts will demonstrate how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed, expertise, and confidence of large hospital networks and university centers.</p> <p>The Break the Data Bottleneck Summit is your opportunity to:</p> <p>Learn how to accelerate your bioinformatics pipeline from FASTQ to report<br> Gain valuable insights into variant curation and the importance of evidence<br> Find out how your lab can stay up-to-date on guidelines, therapies, and trials and generate comprehensive, patient-specific reports</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/76302975/break-the-data-bottleneck-summit"><img src="http://tv.qiagenbioinformatics.com/64968570/76302975/d6ed11cf18ac5e43da7695488466f0fd/standard/download-6-thumbnail.jpg" width="75" height=""/></a></p> clinical oncology summit http://tv.qiagenbioinformatics.com/photo/76259457/break-the-data-bottleneck-summit-1 <p>Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the Data Bottleneck Summit <p>At the Break the Data Bottleneck Summit, our experts will demonstrate how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed, expertise, and confidence of large hospital networks and university centers.</p> <p>The Break the Data Bottleneck Summit is your opportunity to:</p> <p>Learn how to accelerate your bioinformatics pipeline from FASTQ to report<br> Gain valuable insights into variant curation and the importance of evidence<br> Find out how your lab can stay up-to-date on guidelines, therapies, and trials and generate comprehensive, patient-specific reports</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/76259457/break-the-data-bottleneck-summit-1"><img src="http://tv.qiagenbioinformatics.com/64968555/76259457/a757701bd20ca4919a91ed9696dc1043/standard/download-12-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/76259457 Thu, 23 Jun 2022 11:11:56 GMT Break the data bottleneck summit: Precision Oncology Expert Panel in Europe Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the Data Bottleneck Summit At the Break the Data Bottleneck Summit, our experts will demonstrate how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed, expertise, and confidence of large hospital networks and university centers. The Break the Data Bottleneck Summit is your opportunity to: Learn how to accelerate your bioinformatics pipeline from FASTQ to report Gain valuable insights into variant curation and the importance of evidence Find out how your lab can stay up-to-date on guidelines, therapies, and trials and generate comprehensive, patient-specific reports Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the Data Bottleneck Summit At the Break the Data Bottleneck Summit, our experts will demonstrate how small to mid-sized clinical diagnostic labs can compete to... tv.qiagenbioinformatics.com 01:17:32 <p>Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the Data Bottleneck Summit <p>At the Break the Data Bottleneck Summit, our experts will demonstrate how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed, expertise, and confidence of large hospital networks and university centers.</p> <p>The Break the Data Bottleneck Summit is your opportunity to:</p> <p>Learn how to accelerate your bioinformatics pipeline from FASTQ to report<br> Gain valuable insights into variant curation and the importance of evidence<br> Find out how your lab can stay up-to-date on guidelines, therapies, and trials and generate comprehensive, patient-specific reports</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/76259457/break-the-data-bottleneck-summit-1"><img src="http://tv.qiagenbioinformatics.com/64968555/76259457/a757701bd20ca4919a91ed9696dc1043/standard/download-12-thumbnail.jpg" width="75" height=""/></a></p> clinical oncology summit http://tv.qiagenbioinformatics.com/photo/75959093/lower-the-barrier-to-adopt-larger <p><p><span>A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of large hospital networks and university centers. &nbsp;&nbsp;<br>&nbsp;<br>Featured topics at the event include:</span></p><ul><li>Expert tips to improve the accuracy and efficiency of your molecular tumor boards</li><li>How to accelerate your bioinformatics pipeline from FASTQ to report</li><li>How your lab can stay up-to-date on guidelines, therapies, and clinical trials&nbsp;</li></ul><p>Part 1: May 19, 2022 (Americas and Europe)</p><ul><li>QIAGEN Expert Talks</li></ul><p>Part 2: June 16, 2022 (Americas) and June 21, 2022 (Europe)</p><ul><li>Customer Insights</li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/75959093/lower-the-barrier-to-adopt-larger"><img src="http://tv.qiagenbioinformatics.com/64968571/75959093/e9d036feea3b8a2cf3c688f47ee70cf4/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/75959093 Fri, 27 May 2022 17:55:59 GMT Lower the barrier to adopt larger CGP in Dx labs: QIAGEN Expert Talks in US A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of large hospital networks and university centers. Featured topics at the event include:Expert tips to improve the accuracy and efficiency of your molecular tumor boardsHow to accelerate your bioinformatics pipeline from FASTQ to reportHow your lab can stay up-to-date on guidelines, therapies, and clinical trialsPart 1: May 19, 2022 (Americas and Europe)QIAGEN Expert TalksPart 2: June 16, 2022 (Americas) and June 21, 2022 (Europe)Customer Insights A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of large... tv.qiagenbioinformatics.com 01:41:40 <p><p><span>A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of large hospital networks and university centers. &nbsp;&nbsp;<br>&nbsp;<br>Featured topics at the event include:</span></p><ul><li>Expert tips to improve the accuracy and efficiency of your molecular tumor boards</li><li>How to accelerate your bioinformatics pipeline from FASTQ to report</li><li>How your lab can stay up-to-date on guidelines, therapies, and clinical trials&nbsp;</li></ul><p>Part 1: May 19, 2022 (Americas and Europe)</p><ul><li>QIAGEN Expert Talks</li></ul><p>Part 2: June 16, 2022 (Americas) and June 21, 2022 (Europe)</p><ul><li>Customer Insights</li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/75959093/lower-the-barrier-to-adopt-larger"><img src="http://tv.qiagenbioinformatics.com/64968571/75959093/e9d036feea3b8a2cf3c688f47ee70cf4/standard/download-8-thumbnail.jpg" width="75" height=""/></a></p> clinical Clinical Oncology Summit oncology http://tv.qiagenbioinformatics.com/photo/75959081/lower-the-barrier-to-adopt-larger-1 <p><p><span>A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of large hospital networks and university centers. &nbsp;&nbsp;<br>&nbsp;<br>Featured topics at the event include:</span></p><ul><li>Expert tips to improve the accuracy and efficiency of your molecular tumor boards</li><li>How to accelerate your bioinformatics pipeline from FASTQ to report</li><li>How your lab can stay up-to-date on guidelines, therapies, and clinical trials</li></ul><p>Part 1: May 19, 2022 (Americas and Europe)</p><ul><li>QIAGEN Expert Talks</li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/75959081/lower-the-barrier-to-adopt-larger-1"><img src="http://tv.qiagenbioinformatics.com/64968570/75959081/aad35b58bb45fc034ba11f2196a1c891/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/75959081 Fri, 27 May 2022 17:55:04 GMT Lower the barrier to adopt larger CGP in Dx labs: QIAGEN Expert Talks in Europe A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of large hospital networks and university centers. Featured topics at the event include:Expert tips to improve the accuracy and efficiency of your molecular tumor boardsHow to accelerate your bioinformatics pipeline from FASTQ to reportHow your lab can stay up-to-date on guidelines, therapies, and clinical trialsPart 1: May 19, 2022 (Americas and Europe)QIAGEN Expert Talks A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of large... tv.qiagenbioinformatics.com 01:50:45 <p><p><span>A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of large hospital networks and university centers. &nbsp;&nbsp;<br>&nbsp;<br>Featured topics at the event include:</span></p><ul><li>Expert tips to improve the accuracy and efficiency of your molecular tumor boards</li><li>How to accelerate your bioinformatics pipeline from FASTQ to report</li><li>How your lab can stay up-to-date on guidelines, therapies, and clinical trials</li></ul><p>Part 1: May 19, 2022 (Americas and Europe)</p><ul><li>QIAGEN Expert Talks</li></ul></p><p><a href="http://tv.qiagenbioinformatics.com/photo/75959081/lower-the-barrier-to-adopt-larger-1"><img src="http://tv.qiagenbioinformatics.com/64968570/75959081/aad35b58bb45fc034ba11f2196a1c891/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> Clinical Oncology Summit oncology